Agile Therapeutics to Present at Noble Capital Markets’ Thirteenth Annual Investor/Equity Conference
January 19 2017 - 4:15PM
Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty
pharmaceutical company, announced today that its Chief Executive
Officer, Al Altomari will present at Noble Capital Markets’
Thirteenth Annual Investor/ Equity Conference on Tuesday, January
31, 2017 at 11:00 am ET.
To access the live and archived webcasts of the
presentation, visit the Investor Relations section of Agile
Therapeutics website at www.agiletherapeutics.com. The
webcast will be archived on Agile Therapeutics website for 60 days
following the event.
About Agile TherapeuticsAgile
Therapeutics is a forward-thinking women's healthcare company
dedicated to fulfilling the unmet health needs of today's women.
Our product candidates are designed to provide women with
contraceptive options that offer freedom from taking a
daily pill, without committing to a longer-acting method.
Our lead product candidate, Twirla®, (ethinyl estradiol and
levonorgestrel transdermal system), also known as AG200-15, is a
once-weekly prescription contraceptive patch that recently
completed Phase 3 trials. Twirla is based on our proprietary
transdermal patch technology, called Skinfusion®, which is designed
to provide advantages over currently available patches and is
intended to optimize patch adhesion and patient
wearability. For more information, please visit the company website
at www.agiletherapeutics.com.
Contact: Mary Coleman 609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024